We could not find any results for:
Make sure your spelling is correct or try broadening your search.
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Oct. 24, 2023 VANCOUVER, BC, Oct. 24, 2023 /CNW/ - TSX VENTURE COMPANIES MINTO METALS CORP. ...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - DMT Canada NewsWire VANCOUVER, BC, le 23 oct. 2023 VANCOUVER, BC, le 23 oct. 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - DMT Canada NewsWire VANCOUVER, BC, Oct. 23, 2023 VANCOUVER, BC, Oct. 23, 2023 /CNW/ - The following issues have been halted by...
This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17...
• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international clinical-stage leader in psychedelic-based...
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (“Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NYSE...
• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma LONDON, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or...
LONDON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Mr. Peter Rands disposed of an aggregate of 1,532,001 common shares in the capital of Small Pharma Inc. (the “Company”) between September 25, 2023 and...
• Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs • At Week 4, 100% of patients in the...
- La transaction portant sur l'ensemble des actions aboutit à la naissance d'un leader international au niveau clinique dans le domaine des nouvelles thérapies psychédéliques. - - Deux programmes...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions